NCI to Provide $8.5M for New Molecular Analysis Technology Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute is continuing its Innovative Molecular Analysis Technologies Program (IMAT), providing funding for projects that focus on the inception and early development of tools that could significantly impact cancer research.

The funding also could support emerging technologies aimed at transforming research or clinical care, and efforts that aim to advance biospecimen storage, collection, processing, and handling.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.